Document is current
Any future updates will be listed below
-
Authors
Iqbal, Mubasher https://orcid.org/0009-0008-7466-0067
McLennan, Alexandra L. https://orcid.org/0000-0002-1467-8010
Mukhamedshin, Anton https://orcid.org/0009-0009-8818-218X
Dinh, Mai T. P. https://orcid.org/0000-0002-2876-9984
Liu, Qisheng
Junco, Jacob J. https://orcid.org/0000-0002-2435-7739
Mohan, Arvind
Srivaths, Poyyapakkam R. https://orcid.org/0000-0002-0423-2250
Rabin, Karen R.
Fogarty, Thomas P. III https://orcid.org/0000-0002-5109-8525
Gifford, Sean C.
Shevkoplyas, Sergey S. https://orcid.org/0000-0002-8203-8365
Lam, Fong W. https://orcid.org/0000-0003-2034-2625
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HL151858, HL151858)
- License Information
-
More Information
Article History
Received: 17 July 2024
Accepted: 29 January 2025
First Online: 24 February 2025
Competing interests
: S.C.G. and S.S.S. are inventors listed on U.S. Patent #9,789,235 entitled ‘Separation and concentration of particles’, which describes the ‘controlled incremental filtration’ technology. They are also co-founders of Halcyon Biomedical Incorporated, a company that would potentially benefit from the commercialization of this patented technology. S.S.S. has received research funding from Halcyon Biomedical Incorporated. All other authors declare no competing interests.
